Skip to main content
CLOV
NASDAQ Finance

Former CFO Peter Kuipers Files Intent to Sell $3.06M in Shares

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Financial
Sentiment info
Negative
Importance info
7
Price
$3.48
Mkt Cap
$1.826B
52W Low
$1.58
52W High
$3.92
52W Position info
120% above low
Off High info
11% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CLOV has more than doubled off its 52-week low of $1.58.

Summary

Clover Health's former CFO, Peter Kuipers, has filed a Form 144 indicating his intent to sell 886,341 shares valued at approximately $3.06 million.


Key Events · Ownership and Investor Activity · CLOV

  • Former CFO Files Intent to Sell

    Peter Kuipers, the company's former Chief Financial Officer, has filed a Form 144.

  • Significant Share Disposition

    The filing indicates an intent to sell 886,341 shares of common stock.

  • Substantial Market Value

    The proposed sale has an approximate market value of $3.06 million.

  • Shares from Stock Options

    The shares were acquired on April 29, 2025, through a stock plan option.


Analysis · CLOV · Finance

This Form 144 indicates that former CFO Peter Kuipers intends to sell a substantial amount of Clover Health shares, valued at approximately $3.06 million. While the company recently achieved its first-ever positive GAAP Net Income, this significant sale by a former key executive could be interpreted as profit-taking or a liquidity event, potentially adding selling pressure to the stock.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, CLOV was trading at $3.48 on NASDAQ in the Finance sector, with a market capitalization of approximately $1.8B. The 52-week trading range was $1.58 to $3.92. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

CLOV - Latest Insights

CLOV
Nov 06, 2026, 8:03 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $4.45
Real-time Price: $3.71 info
Change: -$0.7402 (-17%) info
Market Cap: $1.976B info
CLOV
Nov 04, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $4.67
Real-time Price: $3.71 info
Change: -$0.960 (-21%) info
Market Cap: $1.976B info
CLOV
Nov 04, 2026, 4:06 PM EST
Source: Reuters
Importance Score:
8
Price at Filing: $4.71
Real-time Price: $3.71 info
Change: -$1.00 (-21%) info
Market Cap: $1.976B info
CLOV
Oct 08, 2026, 6:45 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $5.00
Real-time Price: $3.71 info
Change: -$1.29 (-26%) info
Market Cap: $1.976B info
CLOV
Aug 07, 2026, 8:04 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $4.69
Real-time Price: $3.71 info
Change: -$0.980 (-21%) info
Market Cap: $1.976B info